LCTX

Lineage Cell Therapeutics Inc

$0.90

-0.01 (-1.07%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 02.07.2025
$3.92
(+336.34%)
Strong Buy: 2
Buy: 4
Hold: 1
Sell: 0
Strong Sell: 0
Description:
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment of degenerative diseases in the United States and internationally. The company is headquartered in Carlsbad, California.
Exchange:
NYSE MKT
Country:
USA
Sector:
LIFE SCIENCES
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address:
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, US
Fiscal year end:
December
Market capitalization:
$207 Million
EBITDA:
-$20.7 Million
PERatio:
0.0
EPS:
-0.07
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.524

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-66%
How much will you get:
$336
Prices dates:
30-06-2015: $2.70 and 30-06-2025: $0.91